NasdaqCM - Nasdaq Real Time Price USD
Organogenesis Holdings Inc. (ORGO)
At close: October 21 at 4:00 PM EDT
After hours: October 21 at 4:02 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.01 | -0.01 | -0.17 | -0.04 |
| Low Estimate | -0.02 | -0.03 | -0.2 | -0.25 |
| High Estimate | 0 | 0.01 | -0.14 | 0.09 |
| Year Ago EPS | 0.02 | 0 | 0.04 | -0.17 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 4 |
| Avg. Estimate | 108.83M | 107.23M | 456.15M | 456.51M |
| Low Estimate | 107.3M | 105.3M | 452.8M | 430.1M |
| High Estimate | 110.5M | 109.9M | 458.8M | 497.3M |
| Year Ago Sales | 108.53M | 99.65M | 433.14M | 456.15M |
| Sales Growth (year/est) | 0.30% | 7.60% | 5.30% | 0.10% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0 | 0.01 | -0.03 | 0 |
| EPS Actual | 0.02 | 0 | -0.02 | -0.13 |
| Difference | 0.02 | -0.01 | 0.01 | -0.13 |
| Surprise % | -- | -100.00% | 33.30% | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.01 | -0.01 | -0.17 | -0.04 |
| 7 Days Ago | -0.01 | -0.01 | -0.17 | -0.04 |
| 30 Days Ago | -0.01 | -0.01 | -0.18 | -0.04 |
| 60 Days Ago | -0.01 | -0.01 | -0.13 | -0.04 |
| 90 Days Ago | 0 | 0.01 | -0.01 | 0.01 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ORGO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -150.00% | -- | -- | 3.60% |
| Next Qtr. | -- | -- | -- | 7.90% |
| Current Year | -525.00% | -- | -- | 2.50% |
| Next Year | 76.50% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 2.41% | -- | -- | 11.87% |
| Past 5 Years (per annum) | -39.97% | -- | -- | -- |
Upgrades & Downgrades
| Initiated | Lake Street: Buy | 6/28/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 3/1/2024 |
| Initiated | Cantor Fitzgerald: Overweight | 2/7/2024 |
| Maintains | BTIG: Buy to Buy | 12/27/2023 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 11/14/2023 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 8/11/2023 |
Related Tickers
IRWD Ironwood Pharmaceuticals, Inc.
4.1900
-4.77%
OPTN OptiNose, Inc.
0.7800
-2.50%
INDV Indivior PLC
8.27
-3.39%
ANIK Anika Therapeutics, Inc.
24.44
-2.47%
DRRX DURECT Corporation
1.4300
+8.33%
PETQ PetIQ, Inc.
30.97
+0.13%
TSND.TO TerrAscend Corp.
1.6600
-4.60%
PAHC Phibro Animal Health Corporation
23.65
-1.74%
ASRT Assertio Holdings, Inc.
1.1500
-0.86%
ETON Eton Pharmaceuticals, Inc.
8.44
+1.08%